Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Elderly lymphoma Patients' Well-Being under the microscope

NCT ID NCT05524298

Knowledge-focused Sponsor: Fondazione Italiana Linfomi - ETS Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 11, 2026 · Updated 1 time

Summary

This study follows 150 adults aged 70 and older with low-grade non-Hodgkin lymphoma to see how their quality of life changes during treatment. Researchers will use questionnaires to track well-being from diagnosis through one year after therapy starts. The goal is to identify which factors most affect daily life, helping doctors tailor care for older patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 150 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2022

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Elderly Patients With Low Grade Non-Hodgkin Lymphoma Treated With Immunotherapy Or Immunochemotherapy And/Or Radiotherapy.

Ages

70 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Local histological diagnosis of indolent B cell non-Hodgkin lymphoma: follicular lymphoma, marginal zone lymphoma (nodal, MALT (Mucosa-Associated Lymphoid Tissue), splenic), lymphoplasmacytic lymphoma/ Waldenström macroglobulinemia) * Age ≥ 70 years * Patient candidates to receive treatment for lymphoma * Patient previously untreated for lymphoma * Evaluation of Comprehensive Geriatric Assessment at baseline * Ability to provide informed consent: subject understands and voluntarily signs an informed consent form approved by an IEC (Independent Ethics Committee), prior to registration into the study Note: Patient treated in the context of a clinical trial is admitted Exclusion Criteria: * none

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Follicular lymphoma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

follicular lymphoma indolent B-cell non-Hodgkin lymphoma lymphoplasmacytic lymphoma marginal zone lymphoma Waldenstrom macroglobulinemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Low grade non-Hodgkin's lymphoma, adult

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    21 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • A.O.U. Citta della Salute e della Scienza di Torino - Ematologia Universitaria

    RECRUITING

    Torino, Italy

  • Clinica di Ematologia - A.O.U. Ospedali Riuniti

    RECRUITING

    Ancona, Italy, 60126, Italy

  • Divisione di Ematologia - A.O. Ospedali Riuniti Villa Sofia-Cervello

    RECRUITING

    Palermo, Italy, 90146, Italy

  • Divisione di Oncologia e dei Tumori immuno-correlati - IRCCS Centro di Riferimento Oncologico di Aviano

    RECRUITING

    Aviano, 33081, Italy

  • Ematologia - A.O.U. Policlinico Giaccone

    RECRUITING

    Palermo, Italy, 90127, Italy

  • Ematologia - ASST Spedali Civili di Brescia

    RECRUITING

    Brescia, Italy, 25123, Italy

  • Ematologia - Azienda Unitа Sanitaria Locale-IRCCS - Arcispedale Santa Maria Nuova

    RECRUITING

    Reggio Emilia, Italy, 42123, Italy

  • Ematologia - Ospedale di Castelfranco Veneto

    RECRUITING

    Castelfranco Veneto, Italy, 31033, Italy

  • Ematologia,Trapianto cellule staminali, Medicina Trasfusionale e Terapia cellulare -Policlinico Universitario Campus Bio-Medico

    RECRUITING

    Roma, Italy, 00128, Italy

  • Ospedale San Bassiano - AULSS7 Pedemontana - UOC Oncoematologia

    RECRUITING

    Bassano del Grappa, Vicenza, 36061, Italy

  • S.C. Ematologia - A.O. SS. Antonio e Biagio e Cesare Arrigo

    RECRUITING

    Alessandria, Alessandria, 15121, Italy

  • S.C. Ematologia - ASST Grande Ospedale Metropolitano Niguarda

    RECRUITING

    Milan, Italy, 20162, Italy

  • S.C. Ematologia - Azienda Ospedali Riuniti Papardo-Piemonte

    NOT_YET_RECRUITING

    Messina, Italy, 98158, Italy

  • U.O. Ematologia - Ospedale Guglielmo da Saliceto

    RECRUITING

    Piacenza, Italy, 29121, Italy

  • U.O. di Ematologia - Ospedale degli Infermi di Rimini

    RECRUITING

    Rimini, Italy, 47923, Italy

  • U.O.C. Ematologia - A.O.U. Senese

    RECRUITING

    Siena, Italy, 53100, Italy

  • U.O.C. Ematologia - IRCCS Istituto Tumori Giovanni Paolo II

    RECRUITING

    Bari, Italy, 70124, Italy

  • U.O.C. Ematologia - Ospedale di Circolo

    RECRUITING

    Varese, Italy, 21100, Italy

  • U.O.C. di Ematologia - Azienda Ospedaliera Universitaria Policlinico - Rodolico S. Marco

    RECRUITING

    Catania, Italy, 95123, Italy

  • Unità funzionale di Ematologia - Azienda Ospedaliera Universitaria Careggi

    RECRUITING

    Florence, Italy, 50141, Italy

  • Unitа Linfomi - Dipartimento Oncoematologia, Istituto Scientifico San Raffaele

    RECRUITING

    Milan, Italy, 20132, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.